Process intensification: A game changer for the pharma market

Process intensification: A game changer for the pharma market Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the pharma market. Pharmaceutical manufacturing is a competitive field, with patient demand driving the push for more sustainable products. Enter process intensification (PI) – a transformative approach that promises to revolutionise the pharma market. PI strategies are becoming more prevalent in this ever-evolving landscape, and its core focuses on redesigning production processes, often employing innovative techniques to streamline manufacturing. The goal? To make medicine faster, cheaper, and more sustainable for the planet. Several aspects are central to this approach: